[{"Assets_0_Q1_USD":3952974000.0,"CommonStockSharesOutstanding_0_Q1_shares":254867865.0,"EarningsPerShareBasic_1_Q1_USD":0.83,"EarningsPerShareDiluted_1_Q1_USD":0.81,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":252657000.0,"NetIncomeLoss_1_Q1_USD":210263000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":640799000.0,"StockholdersEquity_0_Q1_USD":2401056000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":258526000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":253231000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20180427"}]